Ozelle to Launch O-Cyte 1 Hematology Analyzer at ADLM 2026

For decades, cellular morphology has remained a cornerstone of hematology, though its reliance on manual expertise often creates bottlenecks in fast-paced clinical environments. Existing image-based tools frequently struggle to balance detailed visual analysis with the high-throughput demands of modern laboratories. O-Cyte 1 aims to resolve this tension through the company’s proprietary AI × CBM technology, which converts raw cell imagery into structured, actionable data.

The system is engineered for scalability, processing up to 60 tests per hour as a standalone unit or reaching 360 tests per hour when configured in a cascaded architecture. According to Raymond, head of Ozelle’s North American division, the platform is intended to make advanced morphology intelligence accessible for everyday diagnostic use rather than keeping it locked behind specialized, low-volume procedures.

Beyond its processing power, the analyzer features a compact, modular footprint designed to minimize maintenance and simplify laboratory logistics. Ozelle will showcase the hardware at Booth 2517 during the ADLM event, scheduled for July 28–30 at the Anaheim Convention Center, as part of a broader strategy to expand its diagnostic footprint across North America, Europe, and Asia.